Crescent Biopharma expands CR-001 clinical studies
Patients are enrolling in standard-of-care chemotherapy combination cohorts of the global Phase 1/2 ASCEND trial; additional ADC combination studies with CR-001 have begun.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.